The University of Chicago Header Logo

Connection

Yusuke Nakamura to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Yusuke Nakamura has written about Lung Neoplasms.
Yusuke Nakamura
Connection Strength
6.033
Lung Neoplasms
  1. Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy? Clin Chem. 2020 07 01; 66(7):946-957.
    View in: PubMed
    Score: 0.311
  2. Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations. Cancer Sci. 2019 Mar; 110(3):867-874.
    View in: PubMed
    Score: 0.283
  3. Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells. Cancer Sci. 2017 Jun; 108(6):1203-1209.
    View in: PubMed
    Score: 0.251
  4. TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer. Cancer Sci. 2017 Mar; 108(3):488-496.
    View in: PubMed
    Score: 0.247
  5. Tracheal Bronchus: Beware of Anomalous Venous Drainage! Ann Thorac Surg. 2017 Mar; 103(3):e285.
    View in: PubMed
    Score: 0.247
  6. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis. Sci Transl Med. 2014 Oct 22; 6(259):259ra145.
    View in: PubMed
    Score: 0.210
  7. Identification of a nuclear protein, LRRC42, involved in lung carcinogenesis. Int J Oncol. 2014 Jul; 45(1):147-56.
    View in: PubMed
    Score: 0.203
  8. Lobectomy of pulmonary metastasis of endometrial stromal sarcoma. Tokai J Exp Clin Med. 2013 Dec 20; 38(4):142-5.
    View in: PubMed
    Score: 0.198
  9. Critical function for nuclear envelope protein TMEM209 in human pulmonary carcinogenesis. Cancer Res. 2012 Aug 15; 72(16):4110-8.
    View in: PubMed
    Score: 0.178
  10. Combined immunotherapy with low-dose IL-2 plus IFN-alpha for metastatic renal cell carcinoma: survival benefit for selected patients with lung metastasis and serum sodium level. Jpn J Clin Oncol. 2011 Aug; 41(8):1023-30.
    View in: PubMed
    Score: 0.166
  11. Successful outcomes using combination therapy of interleukin-2 and interferon-alpha for renal cell carcinoma patients with lung metastasis. Jpn J Clin Oncol. 2010 Jul; 40(7):684-9.
    View in: PubMed
    Score: 0.153
  12. Lobectomy of second primary cancer in survivor of small cell lung cancer with brain metastasis. Ann Thorac Surg. 2009 Mar; 87(3):952-4.
    View in: PubMed
    Score: 0.142
  13. From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma. Gen Thorac Cardiovasc Surg. 2008 Feb; 56(2):43-53.
    View in: PubMed
    Score: 0.132
  14. Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis. Cancer Res. 2007 May 01; 67(9):4113-22.
    View in: PubMed
    Score: 0.125
  15. Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res. 2006 Nov 01; 66(21):10339-48.
    View in: PubMed
    Score: 0.121
  16. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol. 2006 Sep; 29(3):567-75.
    View in: PubMed
    Score: 0.119
  17. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer. Cancer Sci. 2006 Aug; 97(8):737-45.
    View in: PubMed
    Score: 0.118
  18. Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray. Int J Oncol. 2006 Apr; 28(4):799-805.
    View in: PubMed
    Score: 0.116
  19. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 2005 Dec 15; 65(24):11314-25.
    View in: PubMed
    Score: 0.113
  20. Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers. Cancer Res. 2005 Oct 15; 65(20):9176-84.
    View in: PubMed
    Score: 0.112
  21. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 2005 Aug 15; 65(16):7102-10.
    View in: PubMed
    Score: 0.111
  22. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res. 2005 Jul 01; 65(13):5638-46.
    View in: PubMed
    Score: 0.110
  23. ADAM8 as a novel serological and histochemical marker for lung cancer. Clin Cancer Res. 2004 Dec 15; 10(24):8363-70.
    View in: PubMed
    Score: 0.106
  24. Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res. 2003 Nov 01; 63(21):7038-41.
    View in: PubMed
    Score: 0.098
  25. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res. 2003 May; 1(7):485-99.
    View in: PubMed
    Score: 0.095
  26. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene. 2003 Apr 10; 22(14):2192-205.
    View in: PubMed
    Score: 0.094
  27. Diagnostic utility and pitfalls of intraoperative pulmonary imprint cytology based on final pathological diagnoses. Cytopathology. 2019 01; 30(1):74-81.
    View in: PubMed
    Score: 0.070
  28. Free-floating cancer cells in lymph node sinuses of hilar lymph node-positive patients with non-small cell lung cancer. Mol Med Rep. 2018 Jul; 18(1):1081-1087.
    View in: PubMed
    Score: 0.067
  29. Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project. J Epidemiol. 2017 Mar; 27(3S):S49-S57.
    View in: PubMed
    Score: 0.061
  30. Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. Nat Commun. 2016 08 09; 7:12451.
    View in: PubMed
    Score: 0.059
  31. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer. Oncotarget. 2016 Mar 22; 7(12):13621-33.
    View in: PubMed
    Score: 0.058
  32. Critical role of lysine 134 methylation on histone H2AX for ?-H2AX production and DNA repair. Nat Commun. 2014 Dec 09; 5:5691.
    View in: PubMed
    Score: 0.053
  33. Recurrence in regional pulmonary lymph nodes after surgery for isolated pulmonary metastasis from hepatocellular carcinoma. Gen Thorac Cardiovasc Surg. 2016 Jun; 64(6):351-4.
    View in: PubMed
    Score: 0.052
  34. RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer. Mol Cancer Res. 2013 Aug; 11(8):937-51.
    View in: PubMed
    Score: 0.047
  35. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition. Cancer Lett. 2013 Aug 09; 336(1):76-84.
    View in: PubMed
    Score: 0.047
  36. Colorectal cancer metastasis to the thyroid. Osaka City Med J. 2012 Dec; 58(2):67-75.
    View in: PubMed
    Score: 0.046
  37. Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients. Mol Med Rep. 2012 11; 6(5):937-43.
    View in: PubMed
    Score: 0.045
  38. Identification of a novel oncogene, MMS22L, involved in lung and esophageal carcinogenesis. Int J Oncol. 2012 Oct; 41(4):1285-96.
    View in: PubMed
    Score: 0.045
  39. A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet. 2012 Jul 15; 44(8):900-3.
    View in: PubMed
    Score: 0.045
  40. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis. Cancer Sci. 2012 Mar; 103(3):577-86.
    View in: PubMed
    Score: 0.043
  41. In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy. Cancer Immunol Immunother. 2012 Aug; 61(8):1211-20.
    View in: PubMed
    Score: 0.043
  42. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene. Int J Cancer. 2012 Aug 01; 131(3):E179-89.
    View in: PubMed
    Score: 0.043
  43. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer. Clin Cancer Res. 2011 Dec 15; 17(24):7712-22.
    View in: PubMed
    Score: 0.043
  44. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6. Cancer Prev Res (Phila). 2011 Dec; 4(12):2051-61.
    View in: PubMed
    Score: 0.042
  45. Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res. 2011 Oct 01; 17(19):6272-86.
    View in: PubMed
    Score: 0.042
  46. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer. Clin Cancer Res. 2011 Sep 15; 17(18):5889-900.
    View in: PubMed
    Score: 0.042
  47. Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data. Pharmacogenomics. 2011 Jul; 12(7):965-75.
    View in: PubMed
    Score: 0.042
  48. Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. Mol Cancer. 2011 May 28; 10:65.
    View in: PubMed
    Score: 0.041
  49. A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. PLoS One. 2011 Apr 12; 6(4):e18567.
    View in: PubMed
    Score: 0.041
  50. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer. 2011 Feb 01; 128(3):562-73.
    View in: PubMed
    Score: 0.040
  51. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet. 2010 Dec 15; 19(24):4948-54.
    View in: PubMed
    Score: 0.040
  52. Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet. 2010 Oct; 42(10):893-6.
    View in: PubMed
    Score: 0.040
  53. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis. Cancer Res. 2010 Jul 01; 70(13):5337-47.
    View in: PubMed
    Score: 0.039
  54. Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis. Genes Chromosomes Cancer. 2010 Apr; 49(4):353-67.
    View in: PubMed
    Score: 0.038
  55. Activation of WD repeat and high-mobility group box DNA binding protein 1 in pulmonary and esophageal carcinogenesis. Clin Cancer Res. 2010 Jan 01; 16(1):226-39.
    View in: PubMed
    Score: 0.037
  56. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res. 2009 Aug 15; 69(16):6694-703.
    View in: PubMed
    Score: 0.037
  57. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics. 2009 Apr; 9(8):2182-92.
    View in: PubMed
    Score: 0.036
  58. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression. Clin Cancer Res. 2009 Jan 01; 15(1):256-66.
    View in: PubMed
    Score: 0.035
  59. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL. Int J Cancer. 2008 Dec 01; 123(11):2616-25.
    View in: PubMed
    Score: 0.035
  60. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients. Clin Cancer Res. 2008 Apr 15; 14(8):2363-70.
    View in: PubMed
    Score: 0.033
  61. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res. 2007 Dec 15; 67(24):11601-11.
    View in: PubMed
    Score: 0.033
  62. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6624-31.
    View in: PubMed
    Score: 0.032
  63. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer. Cancer Sci. 2007 Dec; 98(12):1902-13.
    View in: PubMed
    Score: 0.032
  64. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res. 2007 Mar 15; 67(6):2517-25.
    View in: PubMed
    Score: 0.031
  65. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer. Mol Cancer Ther. 2007 Feb; 6(2):542-51.
    View in: PubMed
    Score: 0.031
  66. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):434-42.
    View in: PubMed
    Score: 0.031
  67. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res. 2006 Oct 01; 66(19):9408-19.
    View in: PubMed
    Score: 0.030
  68. Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839. Int J Oncol. 2003 Jul; 23(1):29-39.
    View in: PubMed
    Score: 0.024
  69. Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res. 2002 Jun 01; 62(11):3244-50.
    View in: PubMed
    Score: 0.022
  70. Identification of semaphorin3B as a direct target of p53. Neoplasia. 2002 Jan-Feb; 4(1):82-7.
    View in: PubMed
    Score: 0.022
  71. Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors. Clin Immunol. 2016 05; 166-167:48-58.
    View in: PubMed
    Score: 0.014
  72. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis. Genes Chromosomes Cancer. 2013 Feb; 52(2):126-39.
    View in: PubMed
    Score: 0.011
  73. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia. 2011 Oct; 13(10):887-98.
    View in: PubMed
    Score: 0.011
  74. Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Sci. 2011 Jul; 102(7):1298-305.
    View in: PubMed
    Score: 0.010
  75. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. Cancer Sci. 2007 Nov; 98(11):1803-8.
    View in: PubMed
    Score: 0.008
  76. Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers. Cancer Sci. 2004 Dec; 95(12):990-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.